NEW YORK (GenomeWeb News) – High-speed biomedical imaging company Cyntellect said today that it is collaborating with the Burnham Institute for Medical Research to develop new applications for the company’s in situ cellular imaging tool.
 
The San Diego-based company said the agreement gives the Burnham researchers access to its LEAP cell imaging and laser processing platform, while Cyntellect gains commercial rights to certain discoveries produced by the collaboration.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.